- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02307773
Lidocaine Spray on an Endoscope to Improve Tolerance to Endoscopy
January 12, 2015 updated by: Byung Hyo Cha, MD, Cheju Halla General Hospital
Does Use of Lidocaine Spray on an Endoscope Immediately Before Insertion Improve Patient Tolerance to Endoscopy? A Single Center, Case-Control Study.
The investigators tested whether a new method which additional lidocaine spray on the tip of endoscope can increase the tolerance of examinee during endoscopy than conventional pharyngeal anesthesia alone.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
All the patients underwent upper gastrointestinal endoscopy were consecutively enrolled and assigned to case group treated with additional 2 puffs of the 10% lidocaine spray on the tip of endoscope before intubation or control group with conventional pharyngeal anesthesia without further treatment.
And the investigators compared their baseline characteristics, past history, sedation or not, and frequency of retching and belching were measured during the endoscopy.
Study Type
Observational
Enrollment (Actual)
497
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jeju Special Self-Governing Province
-
Jeju-si, Jeju Special Self-Governing Province, Korea, Republic of, 690-766
- Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 89 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All the patients who underwent upper gastrointestinal endoscopy in Endoscopy Room 2, Digestive Disease Center, Halla General Hospital, Jeju, Korea were enrolled consecutively during Nov. 4 2013 - May 7 2014.
Description
Inclusion Criteria:
- All the patients who underwent upper gastrointestinal endoscopy in Endoscopy Room, Cheju Hall General Hospital.
Exclusion Criteria:
- advanced older or younger age (> 90, or < 15 years)
- comorbidities scored greater than III of American Society of Anestheiologists Physical Status Classification System (ASA) score
- history of hypersensitivity reaction to lidocaine
- he pregnant
- therapeutic or emergency endoscopy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Case Group
Treated with additional 2 puffs of the 10% lidocaine spray on the tip of endoscope before intubation with conventional pharyngeal anesthesia
|
Consecutively, all the participants were assigned to case group with additional 2 puffs of the 10% lidocaine spray on the tip of endoscope, same medication which was used for prior pharyngeal anesthesia, or to control group with conventional pharyngeal anesthesia without further treatment.
Then we compared the primary outcome measures, such as, frequency of belching and retching of two groups.
Other Names:
|
Control Group
Treated with conventional pharyngeal anesthesia without further treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of Belching and retching
Time Frame: Participants will be followed for the duration of hospital stay, expected average of 1-2 hours
|
Belching was defined as release of gas from the digestive tract (mainly esophagus and stomach) through the mouth and retching was defined as reverse peristaltic movement of the stomach and esophagus without vomiting.
|
Participants will be followed for the duration of hospital stay, expected average of 1-2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse events
Time Frame: Participants will be followed for the duration of hospital stay, expected average of 1-2 hours
|
Events suspected as Aspiration pneumonia, methemoglobinemia
|
Participants will be followed for the duration of hospital stay, expected average of 1-2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Byung Hyo Cha, M.D., Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital, Jeju, Korea
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999 Aug;45(2):172-80. doi: 10.1136/gut.45.2.172.
- Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974 Jun 22;2(5920):656-9. doi: 10.1136/bmj.2.5920.656.
- Gordon MJ, Mayes GR, Meyer GW. Topical lidocaine in preendoscopic medication. Gastroenterology. 1976 Oct;71(4):564-9.
- Isenberg G. Topical anesthesia: to use or not to use--that is the question. Gastrointest Endosc. 2001 Jan;53(1):130-3. doi: 10.1067/mge.2001.112093. No abstract available.
- Lachter J, Jacobs R, Lavy A, Weisler A, Suissa A, Enat R, Eidelman S. Topical pharyngeal anesthesia for easing endoscopy: a double-blind, randomized, placebo-controlled study. Gastrointest Endosc. 1990 Jan-Feb;36(1):19-21. doi: 10.1016/s0016-5107(90)70915-7.
- Leitch DG, Wicks J, el Beshir OA, Ali SA, Chaudhury BK. Topical anesthesia with 50 mg of lidocaine spray facilitates upper gastrointestinal endoscopy. Gastrointest Endosc. 1993 May-Jun;39(3):384-7. doi: 10.1016/s0016-5107(93)70110-8.
- Soma Y, Saito H, Kishibe T, Takahashi T, Tanaka H, Munakata A. Evaluation of topical pharyngeal anesthesia for upper endoscopy including factors associated with patient tolerance. Gastrointest Endosc. 2001 Jan;53(1):14-8. doi: 10.1067/mge.2001.111773.
- Hedenbro JL, Ekelund M, Jansson O, Lindblom A. A randomized, double-blind, placebo-controlled study to evaluate topical anaesthesia of the pharynx in upper gastrointestinal endoscopy. Endoscopy. 1992 Aug;24(6):585-7. doi: 10.1055/s-2007-1010550.
- Karim A, Ahmed S, Siddiqui R, Mattana J. Methemoglobinemia complicating topical lidocaine used during endoscopic procedures. Am J Med. 2001 Aug;111(2):150-3. doi: 10.1016/s0002-9343(01)00763-x. No abstract available.
- Gunaratnam NT, Vazquez-Sequeiros E, Gostout CJ, Alexander GL. Methemoglobinemia related to topical benzocaine use: is it time to reconsider the empiric use of topical anesthesia before sedated EGD? Gastrointest Endosc. 2000 Nov;52(5):692-3. doi: 10.1067/mge.2000.110078. No abstract available.
- Abdallah HY, Shah SA. Methemoglobinemia induced by topical benzocaine: a warning for the endoscopist. Endoscopy. 2002 Sep;34(9):730-4. doi: 10.1055/s-2002-33450.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2013
Primary Completion (Actual)
May 1, 2014
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
December 1, 2014
First Submitted That Met QC Criteria
December 2, 2014
First Posted (Estimate)
December 4, 2014
Study Record Updates
Last Update Posted (Estimate)
January 13, 2015
Last Update Submitted That Met QC Criteria
January 12, 2015
Last Verified
December 1, 2014
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2013-M08
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tolerance
-
PhytheaCompletedRenal Tolerance | Digestive ToleranceFrance
-
Alcon ResearchNOVARTIS BIOCIENCIAS S/ACompleted
-
Société des Produits Nestlé (SPN)RecruitingToleranceUnited Kingdom
-
Liquid I.V.University of MemphisNot yet recruiting
-
Abbott NutritionCompleted
-
NHS TaysideUniversity of DundeeCompleted
-
University of Illinois at Urbana-ChampaignCompleted
-
Mead Johnson NutritionBaylor College of MedicineCompleted
-
University of Illinois at Urbana-ChampaignCompleted
-
Rousselot BVBANot yet recruiting
Clinical Trials on Case Group
-
Groupe Hospitalier Paris Saint JosephActive, not recruiting
-
University Hospital, BrestUnknownVenous Thromboembolic DiseaseFrance
-
Universidad de ZaragozaInstituto Aragones de Ciencias de la SaludCompleted
-
Saglik Bilimleri UniversitesiCompleted
-
Etlik Zubeyde Hanım Women's Health Care, Training...RecruitingEnteral Feeding | Breast Feeding, Exclusive | Hospital StayTurkey
-
Children's National Research InstituteCompletedPediatric ALL | Concussion, Mild | Concussion, Brain | Concussion, IntermediateUnited States
-
University of AarhusLund UniversityCompletedArthroplasty, Replacement, Hip
-
Göteborg UniversityVastra Gotaland Region; Sahlgrenska University Hospital, Sweden; Forte; Narhalsan...Not yet recruitingFrailty | Integrated Care | Dependence
-
University Hospital, LilleCompletedSuicide, AttemptedFrance
-
Bucheon St. Mary's HospitalRecruitingStomach NeoplasmKorea, Republic of